GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Astrazeneca Pharma India ASTRAZEN.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

6,514.50

+2.21%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Astrazeneca Pharma India

Our reporting

We have not reported on Astrazeneca Pharma India yet.

Past results

Reported against what analysts expected

28 May 20269 Feb 202611 Nov 202514 Aug 202511 Feb 202513 Nov 2024
Earnings per share17.9513.0421.6922.3312.3415.37
Forecast5.168.298.298.298.295.16
Revenue₹5.79bn₹6.12bn₹5.59bn₹5.26bn₹4.40bn₹4.08bn
Forecast₹1.75bn₹2.01bn₹2.01bn₹2.01bn₹2.01bn₹1.75bn

Key events

  1. 15 Jun 200610-for-2 share split
  2. 30 Jul 1998Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.